
Drug-Resistant Candida auris Surges in U.S. Healthcare Settings
A CDC-led report finds that Candida auris, a drug-resistant yeast, is continuing to spread in U.S. healthcare facilities, with 13,507 cases reported from 2022–2024 and cases in more than half the states. Most infections occur in men over 45 in hospitals or long-term care facilities; the fungus can colonize skin and persist on surfaces, complicating outbreak control. It is consistently resistant to fluconazole and increasingly hard to treat with other antifungals, leaving limited options. Some experts suggest climate-related heat could enable the organism’s adaptation, highlighting the ongoing need for stringent infection prevention and disinfection protocols.












